These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14464868)

  • 1. Bradykinin.
    LEWIS GP
    Nature; 1961 Nov; 192():596-9. PubMed ID: 14464868
    [No Abstract]   [Full Text] [Related]  

  • 2. Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.
    Hecquet C; Tan F; Marcic BM; Erdös EG
    Mol Pharmacol; 2000 Oct; 58(4):828-36. PubMed ID: 10999954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic effect of kallikrein against bradykinin.
    Ercan ZS; Türker RK; Torunoglu M
    Arzneimittelforschung; 1978; 28(10):1712-4. PubMed ID: 582675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical remarks on therapy with kallikrein and kallikrein inactivator].
    WERLE E
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963; 303():5-10. PubMed ID: 14000005
    [No Abstract]   [Full Text] [Related]  

  • 6. DETERMINATION OF BRADYKININ AND KALLIKREIN AS DIAGNOSTIC METHODS IN CARDIOVASCULAR DISEASE.
    OATES JA
    Listing Res Cardiovasc Field; 1964; 10():259-60. PubMed ID: 24547441
    [No Abstract]   [Full Text] [Related]  

  • 7. Bradykinin: a vasodepressor polypeptide.
    NAHUM LH
    Conn Med; 1962 Feb; 26():124-5. PubMed ID: 14477991
    [No Abstract]   [Full Text] [Related]  

  • 8. Bradykinin; mechanism of its release by trypsin and kallikrein.
    ROCHA M; SILVA
    Arch Int Pharmacodyn Ther; 1951 Dec; 88(3):271-82. PubMed ID: 14934358
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions.
    Dumke CL; Kim J; Arias EB; Cartee GD
    J Appl Physiol (1985); 2002 Feb; 92(2):657-64. PubMed ID: 11796678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy with kallikrein and protease inhibitors.
    FORELL MM
    Ann N Y Acad Sci; 1963 Feb; 104():368-75. PubMed ID: 13958716
    [No Abstract]   [Full Text] [Related]  

  • 11. Participation of the kallikrein-kinin-receptor system in reflexes arising from neural afferents in the dog epicardium.
    Staszewska-Woolley J; Woolley G
    J Physiol; 1989 Dec; 419():33-44. PubMed ID: 2576069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of bradykinin, serum kallikrein and other endogenous substances on capillary permeability inthe guinea-pig.
    BHOOLA KD; CALLE JD; SCHACHTER M
    J Physiol; 1960 Jun; 152(1):75-86. PubMed ID: 13800362
    [No Abstract]   [Full Text] [Related]  

  • 13. Alteration by kallikrein and bradykinin of the conversion of angiotensin I to angiotensin II in the isolated perfused rat lung.
    Ercan ZS; Bor NM; Torunoğlu M; Türker RK
    Arzneimittelforschung; 1982; 32(1):30-1. PubMed ID: 6174131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bradykinin].
    ROCHA E SILVA M
    Acta Physiol Lat Am; 1962; 12():66-83. PubMed ID: 14492992
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bradykinin and its antagonists].
    COLLIER HO
    Actual Pharmacol (Paris); 1961; 14():53-74. PubMed ID: 13880555
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bradykinin, kallidin and hypertension].
    WERLE E; KEHL R; KOEBKE K
    Biochem Z; 1950; 320(4):372-83. PubMed ID: 14777780
    [No Abstract]   [Full Text] [Related]  

  • 17. [The biological significance of bradykinin, as tissular hormone].
    ROCHA E SILVA M
    Rend Ist Sup Sanit; 1960; 23():797-818. PubMed ID: 13742415
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bradykinin. Structure--synthesis--physio-pharmacological basis].
    KONZETT H; STURMER E; CERLETTI A
    Clin Ter; 1961 Jan; 20():21-34. PubMed ID: 13753031
    [No Abstract]   [Full Text] [Related]  

  • 19. Human decidua is a target tissue for bradykinin and kallikrein: phosphoinositide hydrolysis accompanies arachidonic acid release in uterine decidua cells in vitro.
    Schrey MP; Holt JR; Cornford PA; Monaghan H; al-Ubaidi F
    J Clin Endocrinol Metab; 1992 Feb; 74(2):426-35. PubMed ID: 1309839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large scale preparation of bradykinin.
    HAMBERG U; DEUTSCH HF
    Arch Biochem Biophys; 1958 Aug; 76(2):262-70. PubMed ID: 13572012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.